1Jessner W, Kinaciyan T, Formann E, et al. Severeskin reactions during therapy for chronic hepatitis C associated with delayed hypersensitivity to pegylated interferons [J] .Hepatology, 2002, 36 (4): 361.
2Gomez Rangel JD, Ruiz Delgado GJ, Ruiz Arguelles GJ. Pegylated-interferon induced severe bone marrow hypoplasia in a patient with multiple myeloma receiving thalidomide [J] . Am J Hematol, 2003, 74(4): 290.
3Thorne J, KnopfU. Acute psychosis after injection of pegylated interferon alpha-2a [ J] . Eur Psychiatry,2003, 18 (3): 142.
4WendlingJ, DescampsV, GrossinM, etal. Sarcoidosis during combined interferon alfa and ribavirin therapy in 2 patients with chronic hepattis C [J] . Arch Dermatol, 2002, 138 (5): 546.
5Alfageme Michavila I, Merino Sanchez M, Perez Ronchel J, et al. Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature [J] . Arch Bronconeumol, 2004, 40(1):45.
6Golstein PE, Delforge ML, Deviere J, et al. Reversible myopathy during successful treatment with pegylated interferon andribavirin for acute hepatitis C[J].JViralHepat, 2004, 11(2): 183.
7Primo Vera J. Pegylated interferon-induced diabetes mellitus type 1 in two patients with chronic hepatitis C[J]. GastroenterolHepatol, 2004, 27(2): 69.
8Thomas WL Jr, Ramos F, Hospenthal DR. Adverse response to pegylated interferon therapy in two patients with chronic hepatitis C [ J] . Hawaii Med J, 2003,62(8): 163.
10GallelliL, GuadagninoV, CaroleoB, etal. Bilateral skin ulceration after injection of pegylated interferon-alpha-2b in a patient with chronic hepatitis C [ J] . Clin DrugInvest, 2003, 23 (6): 615.
